Stocktoria
X4 Pharmaceuticals, Inc XFOR
Nasdaq · XNAS · stock · Biological Products, (No Diagnostic Substances) · website · IPO 2017-11-16
X4 Pharmaceuticals, Inc insider transactions (Form 4)
| Insider | Role | Date | Action | Shares | Price |
|---|---|---|---|---|---|
| KIRSKE DAVID | Chief Financial Officer | 2026-05-12 | Sell | 16,961 | $4.29 |
| Craig Adam R | Executive Chairman | 2025-10-23 | Buy | 86,206 | $2.90 |
| Volpone John | President | 2025-08-14 | Grant | 289,881 | — |
Source: SEC EDGAR filings · CIK 0001501697 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.